Norgestrel Chemical Structure (Lowogestrel 01)
Low-ogestrel Kit
Product Images NDC 51862-564
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Low-ogestrel (NDC 51862-564). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ethinyl Estradiol Chemical Structure (Lowogestrel 02)
Lowogestrel 02a
Relevant studies regarding the risk of breast cancer with combined oral contraceptives are available. The studies include MCHO Women's vs. Marchbanks PA 2002, French 5w cobortey, Oumen 2005, Shangr Wme's st Sy, Oorgach T 2009, The s Heath Sty, Oudrd Py Panin Ve 3613 =105110, T Mo Haath Sty, and Ownah Sx HormoneRegater S, Mch 5, 2017 - SR.*
Table Ii (Lowogestrel 03)
This is a description of different types of birth control methods and their effectiveness rates. The text mentions different levels of pregnancy rates per 100 women, as well as various birth control methods such as pills, injections, intrauterine devices, sterilization, condoms, diaphragm, and natural family planning methods like avoiding sex during the most fertile days, using spermicide or withdrawal.*
Pill Pack (Lowogestrel 04)
Principal Display Panel (Kit Carton)
Low-Ogestrel is a contraceptive medication that comes in the form of tablets. It contains norgestrel and ethinyl estradiol as active ingredients. Each pack has 28-day regimen with 21 white tablets containing norgestrel 0.3 mg and ethinyl estradiol 0.03 mg, and 7 peach-colored tablets with inert ingredients. It is important to take one tablet daily as directed by the doctor. Low-Ogestrel is intended to prevent pregnancy and is not effective in protecting against sexually transmitted diseases. It is distributed by Mayne Pharma and is a product of Canada. Stored at controlled room temperature between 20° to 25°C (68° to 77°F). Full prescribing information is included in the package.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
